Skip to main content
Erschienen in: Reactions Weekly 1/2019

01.10.2019 | Case report

Desvenlafaxine/escitalopram/mirtazapine

Takotsubo cardiomyopathy and hyponatraemia: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Johnson JCS, et al. Takotsubo cardiomyopathy in the context of major neurocognitive disorder and multiple risk factors. Swiss Archives of Neurology, Psychiatry and Psychotherapy 170: No. 3, 19 Jun 2019. Available from: URL: http://doi.org/10.4414/sanp.2019.03022 - Australia Johnson JCS, et al. Takotsubo cardiomyopathy in the context of major neurocognitive disorder and multiple risk factors. Swiss Archives of Neurology, Psychiatry and Psychotherapy 170: No. 3, 19 Jun 2019. Available from: URL: http://​doi.​org/​10.​4414/​sanp.​2019.​03022 - Australia
Metadaten
Titel
Desvenlafaxine/escitalopram/mirtazapine
Takotsubo cardiomyopathy and hyponatraemia: case report
Publikationsdatum
01.10.2019
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-019-68886-7

Weitere Artikel der Ausgabe 1/2019

Reactions Weekly 1/2019 Zur Ausgabe

Case report

Denosumab

Case report

Pazopanib

Case report

Fingolimod

Case report

Etanercept